Beclometasone/ formoterol/ glycopyrronium pMDI for maintenance treatment of moderate to severe COPD

Description

In this Product Explainer, Dr Philip Lee explains the role of beclomethasone/ formoterol/ glycopyrronium pressurised metered dose inhalers (pMDIs) for maintenance treatment of adults with moderate to severe COPD who are not adequately treated by ICS/LABA or LABA/LAMA (7 mins).

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Dr Jane Elliott AM & Prof Rod Baber AM

Dr Jane Elliott AM & Prof Rod Baber AM

Non-Hormonal Options for Menopausal Symptoms

Prof Rukshen Weerasooriya

Prof Rukshen Weerasooriya

Holter Monitoring in GP – Cases and Practical Tips

Dr Rupert Hinds

Dr Rupert Hinds

Management of Constipation in Children

A/Prof Greg Katsoulotos

A/Prof Greg Katsoulotos

Inhaler Devices – Common User Errors

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Dr Philip Lee

expert

Dr Philip Lee

Respiratory and Sleep Physician; Consultant, Respiratory and Sleep Medicine, St George and Northern Beaches Hospitals

Date published: 14 August 2024